fexofenadine and Daytime Sleepiness

fexofenadine has been researched along with Daytime Sleepiness in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sawatsubashi, M	1
Boev, R; De Vos, C; Derde, MP; Mitchev, K; Pinelli, ME	1
Mason, J; Nelson, HS; Reynolds, R	1

Reviews

1 review(s) available for fexofenadine and Daytime Sleepiness

Article	Year
[Clinical Management of Japanese Cedar Pollinosis]. Fukuoka igaku zasshi = Hukuoka acta medica, 2016, Volume: 107, Issue:1 Topics: Administration, Inhalation; Cedrus; Desensitization, Immunologic; Disorders of Excessive Somnolence; Drug Combinations; Environmental Exposure; Glucocorticoids; Histamine H1 Antagonists, Non-Sedating; Humans; Nasal Obstruction; Nonprescription Drugs; Patient Satisfaction; Pollen; Practice Guidelines as Topic; Pseudoephedrine; Rhinitis, Allergic, Seasonal; Seasons; Surveys and Questionnaires; Terfenadine	2016

Article

Year

[Clinical Management of Japanese Cedar Pollinosis].

Fukuoka igaku zasshi = Hukuoka acta medica, 2016, Volume: 107, Issue:1

Topics: Administration, Inhalation; Cedrus; Desensitization, Immunologic; Disorders of Excessive Somnolence; Drug Combinations; Environmental Exposure; Glucocorticoids; Histamine H1 Antagonists, Non-Sedating; Humans; Nasal Obstruction; Nonprescription Drugs; Patient Satisfaction; Pollen; Practice Guidelines as Topic; Pseudoephedrine; Rhinitis, Allergic, Seasonal; Seasons; Surveys and Questionnaires; Terfenadine

2016

Trials

1 trial(s) available for fexofenadine and Daytime Sleepiness

Article	Year
Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2000, Volume: 84, Issue:5 Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Chronic Disease; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Histamine H1 Antagonists; Humans; Male; Middle Aged; Nausea; Terfenadine; Therapeutic Equivalency; Urticaria; Xerophthalmia; Xerostomia	2000

Article

Year

Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2000, Volume: 84, Issue:5

Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Chronic Disease; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Histamine H1 Antagonists; Humans; Male; Middle Aged; Nausea; Terfenadine; Therapeutic Equivalency; Urticaria; Xerophthalmia; Xerostomia

2000

Other Studies

1 other study(ies) available for fexofenadine and Daytime Sleepiness

Article	Year
Non-interventional study comparing treatment satisfaction in patients treated with antihistamines. Clinical drug investigation, 2008, Volume: 28, Issue:4 Topics: Activities of Daily Living; Administration, Oral; Adult; Aged; Aged, 80 and over; Cetirizine; Child; Child, Preschool; Data Collection; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Europe; Female; Histamine H1 Antagonists; Humans; Infant; Male; Middle Aged; Patient Satisfaction; Piperazines; Prevalence; Rhinitis, Allergic, Seasonal; Terfenadine; Treatment Outcome; Urticaria	2008

Article

Year

Non-interventional study comparing treatment satisfaction in patients treated with antihistamines.

Clinical drug investigation, 2008, Volume: 28, Issue:4

Topics: Activities of Daily Living; Administration, Oral; Adult; Aged; Aged, 80 and over; Cetirizine; Child; Child, Preschool; Data Collection; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Europe; Female; Histamine H1 Antagonists; Humans; Infant; Male; Middle Aged; Patient Satisfaction; Piperazines; Prevalence; Rhinitis, Allergic, Seasonal; Terfenadine; Treatment Outcome; Urticaria

2008